Praxis Precision Medicines
NASDAQ: PRAXCambridge, US · Founded 2015 · Delaware corporation · 3 known investors
Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.
Founders & leadership
KR
Kiran ReddyExecutive
Board
NG
Nicholas G. GalakatosBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$31.9M disclosed across 3 rounds · 2016–2019
▶$10MraisedJun 2019 · 5 investors · PharmaceuticalsRule 506(b)
▶$10MraisedJun 2019 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- KIRAN REDDYExecutive Officer, Director
- NICHOLAS GALAKATOSDirector
- THOMAS DYRBERGDirector
- STEFAN VITOROVICDirector
- STUART CHAFFEEExecutive Officer
- WILLIAM YOUNGDirector
- PAUL MEDEIROSDirector
- ARI BRETTMANDirector
- GREGORY NORDENDirector
- ALFRED SANDROCKDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$18.8MraisedMar 2018 · 6 investors · PharmaceuticalsRule 506(b)
▶$18.8MraisedMar 2018 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- William D. YoungDirector
- Alfred Sandrock, Jr.Director
- Nicholas G. GalakatosDirector
- Stuart ChaffeeExecutive Officer
- Kiran ReddyExecutive Officer, Director
- Offering amount
- $46.4M
- Amount sold
- $18.8M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.1MraisedNov 2016 · 2 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedNov 2016 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas G. GalakatosDirector
- Kiran ReddyExecutive Officer, Director
- Offering amount
- $7.7M
- Amount sold
- $3.1M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Praxis Precision Medicines do?
- Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.
- Who are Praxis Precision Medicines's investors?
- Praxis Precision Medicines's investors include OCV Partners, Clarus, Vida Ventures.
- How much funding has Praxis Precision Medicines raised?
- Praxis Precision Medicines has disclosed $31.9M raised across 3 rounds.
- Where is Praxis Precision Medicines headquartered?
- Praxis Precision Medicines is headquartered in Cambridge, US.